99.1% Purity
BESTSELLER
Complimentary shipping over $350 · Every lot independently verified · For laboratory research use only
Metabolic Research
Price range: $90.00 through $170.00
30mg lyophilized vial · COA included
Bundle & Save
Description
Tirzepatide is a dual-pathway research peptide widely studied for laboratory investigation of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor signaling. Its dual-receptor profile enables researchers to evaluate receptor interaction, intracellular communication, and endocrine pathway coordination within controlled research environments.
This compound is supplied exclusively for scientific and preclinical laboratory investigations.
Specifications
Product Classification: Research Use Only (RUO)
Total Content: 30 mg lyophilized peptide per vial
Compound: Tirzepatide
Form: Sterile lyophilized powder
Purity: ≥99%
Storage: Store frozen at −20°C and protect from moisture.
Packaging: Glass laboratory vial.
Applications
Laboratory investigations include:
Warning
For laboratory research purposes only.
Not intended for human consumption, animal use, or clinical application.
Scientific Report
Abstract
Tirzepatide is a synthetic dual receptor peptide investigated in laboratory models involving GLP-1 and GIP signaling. Its research profile supports studies evaluating endocrine pathway coordination, receptor activation, intracellular communication, and downstream cellular responses.
Mechanistic Pathway
GLP-1 Pathway
Supports laboratory research examining GLP-1 receptor-associated signaling and downstream cellular activity.
GIP Pathway
Used to investigate GIP receptor activation and associated endocrine signaling mechanisms.
Dual Receptor Interaction
Allows researchers to examine coordinated activity between GLP-1 and GIP pathways.
Pharmacokinetic / Research Profile
| Compound | Primary Pathways | Research Focus |
| Tirzepatide | GLP-1 • GIP | Dual receptor signaling models |
Research Models
Designed exclusively for controlled laboratory and in vitro studies investigating peptide signaling pathways.
No human or veterinary dosing information is provided.
Preclinical Research Highlights
Conclusion
Tirzepatide provides researchers with a dual-receptor investigational peptide suitable for examining GLP-1 and GIP pathway interactions, receptor communication, and endocrine signaling within controlled laboratory environments.
YOU MAY ALSO LIKE
99.1% Purity
BESTSELLER